NCT01682382View on ClinicalTrials.gov

Association of Macular Pigment Optical Density (MPOD) and Genetic Variants in Complement Factor H in Subjects With Choroidal Neovascular (CNV)

CompletedOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

August 31, 2013

Study Completion Date

October 31, 2013

Conditions
Age-related Macular DegenerationChoroidal Neovascular Age-related Macular Degeneration
Trial Locations (1)

92024

Morris Eye Group, Encinitas

All Listed Sponsors
lead

Sequenom, Inc.

INDUSTRY

NCT01682382 - Association of Macular Pigment Optical Density (MPOD) and Genetic Variants in Complement Factor H in Subjects With Choroidal Neovascular (CNV) | Biotech Hunter | Biotech Hunter